Pharmaceutical Grade Gelatin

Pharmaceutical Grade Gelatin Market Outlook

The global pharmaceutical grade gelatin market was valued at approximately USD 1.5 billion in 2022, and it is projected to reach around USD 2.5 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period. The increasing demand for pharmaceutical and nutraceutical applications, along with the growing popularity of soft and hard gelatin capsules, is driving the market growth. Furthermore, the rising trend towards health and wellness products combined with the expansion of the pharmaceutical industry globally also fuels this market's expansion. In addition, the advancements in gelatin extraction processes and the increasing adoption of gelatin in various applications such as cosmetics and food additives contribute to the market's growth. As the pharmaceutical industry seeks to enhance drug delivery systems, the demand for pharmaceutical-grade gelatin is expected to surge significantly.

Growth Factor of the Market

The growth of the pharmaceutical grade gelatin market can be attributed to several interrelated factors that enhance its demand across various sectors. The increasing global population and the surging incidence of chronic diseases have led to a growing need for effective and innovative drug delivery systems, for which gelatin plays a vital role. Additionally, the rising awareness of dietary supplements and nutraceuticals is catalyzing the demand for gelatin-based products, particularly soft gelatin capsules, which are favored for their ease of swallowing and higher bioavailability. The pharmaceutical industry is also witnessing rapid advancements in drug formulations, wherein gelatin serves as a crucial excipient. Furthermore, the cosmetic industry's ongoing emphasis on natural and biocompatible ingredients makes gelatin a favorable choice for manufacturers, thus broadening its application scope. The expansion of research laboratories seeking gelatin for various testing and formulation purposes further enhances market dynamics, underscoring the importance of pharmaceutical-grade gelatin in multiple domains.

Key Highlights of the Market

• The global pharmaceutical grade gelatin market is expected to grow at a CAGR of 4.7% from 2022 to 2035.
• Soft gelatin capsules are anticipated to hold the largest market share due to their widespread use in nutraceuticals and pharmaceuticals.
• North America is the leading region in the pharmaceutical grade gelatin market, accounting for a significant percentage of global revenue.
• The increasing trend towards health and wellness products significantly contributes to the demand for gelatin.
• The rise of research labs and demand for innovative drug delivery systems are driving new opportunities in the market.

By Product Type

Hard Gelatin Capsules:

Hard gelatin capsules are extensively utilized in the pharmaceutical and nutraceutical industries due to their favorable characteristics, including ease of manufacturing, dosage accuracy, and stability. They are typically composed of gelatin that is derived from animal collagen, providing a suitable medium for encapsulating powdered ingredients. The hard capsule market is gaining traction due to the increasing demand for solid-dose formulations that promote better stability and extended shelf life. Furthermore, as the trend towards personalized medicine expands, hard gelatin capsules offer the flexibility for customization in formulation, which is particularly appealing to manufacturers aiming for tailored drug delivery solutions. The rising preference for vegetarian and alternative sources of gelatin is also influencing product innovations within this segment, with the introduction of plant-based alternatives gaining momentum.

Soft Gelatin Capsules:

Soft gelatin capsules are gaining significant popularity owing to their enhanced bioavailability and patient compliance. These capsules are designed to encapsulate liquid formulations, making them especially suitable for oils and extracts. The nutraceutical sector, in particular, has embraced soft gelatin capsules as they provide an efficient means for delivering essential nutrients, vitamins, and herbal extracts. The market for soft gelatin capsules is expected to witness robust growth, driven by the increasing consumer inclination towards dietary supplements and natural health products. Additionally, the growing prevalence of chronic diseases that necessitate consistent medication regimes further propels the demand for soft gelatin capsules, as they are easier to swallow and offer faster digestion compared to traditional tablets.

Gelatin Coated Tablets:

Gelatin-coated tablets serve as an innovative alternative to traditional tablets, providing both the benefits of gelatin and the ease of use associated with pill form. These tablets are particularly appealing to consumers who have difficulty swallowing regular tablets and capsules. The coating not only enhances the appearance but also provides a layer of protection for the active ingredients, ensuring their stability and efficacy over time. The rising trend towards convenience in medication, coupled with the growing awareness of health and wellness, is expected to drive demand for gelatin-coated tablets. As pharmaceutical companies aim to improve patient adherence to medication, gelatin-coated tablets are becoming an increasingly popular choice, especially in pediatric and geriatric demographics.

Hydrolyzed Gelatin:

Hydrolyzed gelatin, also known as collagen peptides, is produced by hydrolysis of gelatin, allowing it to be used in applications that require high bioavailability and rapid absorption. This type of gelatin is gaining traction in the nutraceutical and food industries due to its health benefits, including improved joint health, skin elasticity, and overall wellness. Market demand is driven by the growing trend of functional foods and supplements that promote health and beauty from within. Hydrolyzed gelatin is often found in protein supplements and sports nutrition products, appealing to health-conscious consumers and athletes. The versatility of hydrolyzed gelatin allows it to be incorporated into various formulations, further expanding its market presence across diverse applications.

By Application

Nutraceuticals:

The nutraceuticals segment is one of the largest consumers of pharmaceutical-grade gelatin, driven by the growing awareness of health and wellness among consumers. Gelatin is commonly used in the production of dietary supplements, including vitamins, minerals, and herbal extracts, particularly in the form of soft and hard capsules. The demand for gelatin in nutraceuticals is expected to grow as consumers increasingly seek natural, effective, and easy-to-consume products that support their health goals. The rise of preventative healthcare and self-medication trends is likely to further enhance the demand for gelatin-based nutraceuticals, particularly as the aging population seeks products that promote longevity and well-being.

Pharmaceuticals:

The pharmaceutical application of gelatin is vast, serving as a crucial excipient in drug formulations. Gelatin is primarily used in the production of capsules, tablets, and as a binder in various formulations. Its biocompatibility and versatility make it an essential ingredient in formulating drugs that require specific release profiles and stability. As the pharmaceutical industry continues to innovate with new drug delivery systems, the demand for pharmaceutical-grade gelatin is anticipated to increase significantly. Moreover, the rising prevalence of chronic diseases and the focus on personalized medicine are expected to drive growth in this segment, as new drug formulations often incorporate gelatin for its beneficial properties.

Cosmetics:

The cosmetics application segment is experiencing growth as consumers become more discerning about the ingredients in their beauty products. Pharmaceutical-grade gelatin is often utilized in formulations for skin care products, makeup, and hair treatments due to its hydrating and film-forming properties. The increasing trend towards natural and sustainable ingredients in cosmetics is fostering a shift towards gelatin-based products, as they offer a plant-based alternative to synthetic binders and fillers. Moreover, as the demand for cruelty-free and environmentally friendly cosmetics rises, gelatin derived from sustainable sources is likely to see increased adoption in the beauty industry.

Research Labs:

Research laboratories play a pivotal role in driving demand for pharmaceutical-grade gelatin, as it is utilized in various testing, formulation, and experimental applications. Gelatin serves as a versatile medium for growing cultures, as well as in histological specimens and drug testing. The rising investment in R&D across the pharmaceutical and biotechnology sectors is expected to bolster the demand for gelatin in research labs. As new technologies and methodologies emerge in scientific research, gelatin will continue to be a critical ingredient for creating reliable and reproducible results, thus sustaining its market presence in this segment.

By Distribution Channel

Online Stores:

The online distribution channel has gained significant traction in the pharmaceutical grade gelatin market, driven by the convenience and accessibility it offers to consumers and businesses alike. With the rise of e-commerce platforms and the increasing trend of online shopping, manufacturers and wholesalers are leveraging digital channels to reach a broader audience. Online stores provide a convenient way for consumers to access a variety of gelatin products, including dietary supplements and pharmaceutical formulations, often with customer reviews and product comparisons. The growing digitalization of the retail landscape is expected to further boost the online sales of pharmaceutical grade gelatin, especially as more consumers shift to online shopping for health and wellness products.

Drug Stores:

Drug stores remain a significant distribution channel for pharmaceutical-grade gelatin, serving as a critical point of access for consumers seeking health-related products. These establishments typically stock a range of gelatin-based products, including capsules and supplements, catering to the needs of health-conscious consumers. The presence of knowledgeable staff in drug stores also enhances consumer confidence, allowing for informed purchasing decisions regarding health products. The steady demand for pharmaceuticals and nutraceuticals in drug stores is expected to continue driving sales of pharmaceutical-grade gelatin, particularly as consumers prioritize convenience and accessibility in their health and wellness journeys.

Specialty Stores:

Specialty stores, particularly those focused on health and wellness, are vital distribution channels for pharmaceutical-grade gelatin. These stores often provide a curated selection of high-quality gelatin products, emphasizing natural ingredients and health benefits. The growing consumer interest in clean label products and transparency in sourcing has led specialty stores to become important hubs for gelatin-based supplements and pharmaceuticals. As the trend towards personalized health solutions continues, specialty stores are likely to thrive, offering tailored products that meet the specific needs of health-conscious customers. This segment is expected to see sustained growth as consumers increasingly seek specialized products that align with their health goals.

Direct Sales:

Direct sales channels offer an alternative means of distributing pharmaceutical-grade gelatin products, particularly through direct-to-consumer models. This approach allows manufacturers to establish a direct relationship with their customers, enhancing brand loyalty and providing a personalized shopping experience. Direct sales are particularly popular among companies that focus on niche markets, including organic and natural gelatin products, where consumer trust is paramount. As the focus on health and wellness continues to grow, direct sales channels are likely to expand, providing customers with easy access to high-quality gelatin products while allowing manufacturers to maintain control over product marketing and customer engagement.

By Ingredient Type

Type A Gelatin:

Type A gelatin is derived from pig skin and is known for its superior gelling properties and clarity. This type of gelatin is widely used in the pharmaceutical industry for the production of capsules and tablets, as it provides an excellent medium for delivering active ingredients. Its ability to form clear gels makes it particularly appealing for applications where appearance is important, such as in the production of soft gelatin capsules. The demand for Type A gelatin is primarily driven by its versatility and effectiveness in various formulations, making it a staple ingredient in both pharmaceuticals and nutraceuticals.

Type B Gelatin:

Type B gelatin is primarily derived from bovine hides, offering different gelling properties compared to Type A. It is favored in applications requiring a stronger and firmer gel, such as in the production of confectionery and a variety of pharmaceutical products. The use of Type B gelatin in the pharmaceutical industry is growing, particularly in the development of hard capsules and as a thickening agent in various formulations. As consumer demand shifts towards high-quality and reliable products, Type B gelatin's unique properties position it as a valuable ingredient in the pharmaceutical grade gelatin market.

Type AB Gelatin:

Type AB gelatin is a blend of both Type A and Type B gelatins, combining properties from both sources to provide a versatile ingredient suitable for various applications. This type of gelatin offers improved gelatinization and clarity, making it ideal for both pharmaceutical and food applications. The increasing trend towards hybrid formulations has driven the demand for Type AB gelatin, as it allows manufacturers to leverage the benefits of both types while addressing diverse consumer needs. Its adaptability and performance in a wide range of products make Type AB gelatin a growing segment in the pharmaceutical grade gelatin market.

Type O Gelatin:

Type O gelatin is derived from sources that are free from any animal components, making it suitable for vegetarian and vegan applications. With the rising demand for plant-based and dietary-restricted products, Type O gelatin is gaining popularity in the food and pharmaceutical industries. Its ability to form gels and stabilize emulsions makes it a suitable ingredient for various formulations, particularly in the nutraceutical sector. As consumer preferences shift towards more sustainable and cruelty-free options, the demand for Type O gelatin is expected to rise significantly, positioning it as a promising segment within the pharmaceutical grade gelatin market.

Type S Gelatin:

Type S gelatin, often referred to as fish gelatin, is becoming increasingly popular due to its unique properties and suitability for specific dietary requirements. It is derived from fish skin and bones, making it an ideal alternative for those seeking a non-mammalian source of gelatin. Type S gelatin also boasts excellent gelling properties and is more stable in acidic environments, making it suitable for various applications in the food and pharmaceutical sectors. The growing consumer awareness regarding sustainable sourcing and the demand for marine-based ingredients are driving the adoption of Type S gelatin, highlighting its potential to capture a significant market share in the pharmaceutical grade gelatin landscape.

By Region

The North American region holds a dominant position in the pharmaceutical grade gelatin market, accounting for over 35% of the global market share in 2022. The robust pharmaceutical and nutraceutical industries in the United States and Canada are primary drivers of this growth. Additionally, the increasing demand for innovative drug delivery systems and dietary supplements is expected to sustain market expansion in this region. The trend towards personalized medicine and advanced pharmaceutical formulations further bolsters the market, supported by significant investments in research and development. The North American pharmaceutical grade gelatin market is projected to grow at a CAGR of 5.2% through 2035, reflecting the region's strong focus on health and wellness products.

In Europe, the pharmaceutical grade gelatin market is also witnessing substantial growth, driven by a combination of factors including the rising demand for high-quality pharmaceutical products and an increasing population focused on health and wellness. The region accounted for nearly 30% of the global market share in 2022. The presence of a well-established pharmaceutical sector, along with stringent regulations ensuring product quality and safety, further enhances the demand for pharmaceutical-grade gelatin. The European market is expected to grow at a CAGR of 4.5% during the forecast period, signifying steady growth despite challenges such as regulatory compliance and competition from alternative ingredients.

Opportunities

The pharmaceutical grade gelatin market is poised for significant opportunities driven by the increasing demand for innovative drug delivery systems. As healthcare professionals and researchers explore new methodologies to enhance the efficacy of pharmaceuticals, gelatin's versatile properties are being recognized for their potential in various applications, including targeted drug delivery and controlled release formulations. Furthermore, the rise of personalized medicine presents a unique opportunity for gelatin manufacturers to create tailored solutions that meet the specific needs of patients. The growing trend of preventive healthcare and self-medication, particularly among aging populations, is also expected to drive demand for gelatin-based products, offering a lucrative avenue for market expansion.

Another significant opportunity arises from the increasing consumer preference for clean label and natural products. As health-conscious consumers become more vigilant about ingredient sourcing and formulation transparency, the demand for natural and biocompatible ingredients, such as pharmaceutical-grade gelatin, is expected to rise. Manufacturers that prioritize sustainable sourcing and offer innovative, health-focused formulations will find themselves well-positioned to capture market share. The integration of advanced technologies, such as biotechnology and plant-based alternatives, further facilitates market growth, allowing companies to meet diverse consumer preferences while addressing sustainability concerns in the gelatin supply chain.

Threats

Despite the promising growth prospects, the pharmaceutical grade gelatin market faces several threats that could impede its progress. One of the primary threats includes the rising competition from alternative ingredients, such as plant-based thickeners and binders, which may gradually reduce the demand for animal-derived gelatin. As consumers become more health-conscious and environmentally aware, the shift towards vegetarian and vegan products is likely to accelerate, posing challenges for traditional gelatin manufacturers. Additionally, the fluctuating prices of raw materials and potential supply chain disruptions due to regulatory changes or environmental factors could significantly impact production costs and market stability. The ongoing scrutiny and regulatory compliance requirements related to animal sourcing and product safety could also create hurdles for manufacturers seeking to maintain product integrity while meeting evolving consumer demands.

Furthermore, the increasing prevalence of allergic reactions and dietary restrictions associated with gelatin derived from animal sources presents a significant concern for manufacturers. This could lead to decreased consumer acceptance of traditional gelatin products and compel manufacturers to invest in alternative formulations or invest in extensive consumer education to alleviate concerns. Additionally, the fluctuating demand for gelatin-based products in different applications may create uncertainties in market dynamics, driving companies to diversify their product offerings to stay competitive. As the market landscape evolves, addressing these threats will be critical for companies seeking to sustain their positions in the pharmaceutical grade gelatin market.

Competitor Outlook

• Gelita AG
• PB Gelatins
• FMC Corporation
• Jungbunzlauer Suisse AG
• Rousselot
• Ewald Gelatin
• GELITA USA Inc.
• Weishardt Holding
• Nitta Gelatin Inc.
• Collagen Solutions Plc
• ShangHai Dingsheng Chemical Technology Co., Ltd.
• Jiangxi Gelatin Co., Ltd.
• Norland Products Inc.
• Soochow University Gelatin Co., Ltd.
• Qingdao Haizheng Gelatin Co., Ltd.

The competitive landscape of the pharmaceutical grade gelatin market is characterized by a mix of established players and emerging companies, all vying for market share through various strategies. Major companies in this market focus on product innovation, strategic collaborations, and geographic expansion to enhance their presence and cater to the growing demand for pharmaceutical-grade gelatin. For instance, industry leaders like Gelita AG and Rousselot dominate the market with their extensive product ranges and strong operational capabilities. These companies are investing in research and development to create innovative gelatin formulations that address the specific needs of various applications, thus ensuring their competitive edge in the market.

Moreover, companies are increasingly adopting sustainable practices and sourcing strategies to align with consumer demand for environmentally friendly products. Organizations such as PB Gelatins and Weishardt Holding are enhancing their product portfolios to include plant-based gelatin alternatives that cater to the growing vegan and vegetarian markets. As the regulatory landscape continues to evolve, companies are also focusing on compliance with stringent standards to ensure product quality and safety, thus reinforcing their reputation and consumer trust. The competitive landscape is further being shaped by mergers and acquisitions, with companies seeking to expand their capabilities and market reach through strategic partnerships.

In conclusion, the pharmaceutical grade gelatin market is witnessing robust growth driven by increasing demand across various applications, coupled with evolving consumer preferences. Major companies are actively pursuing strategies that emphasize innovation, sustainability, and market diversification. Key players such as Gelita AG and Rousselot are leading the charge, leveraging their expertise and resources to meet the dynamic needs of the pharmaceutical and nutraceutical industries. As the market continues to expand, companies that prioritize product quality, sustainability, and consumer engagement are likely to thrive in this competitive landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Gelita AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Rousselot
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 PB Gelatins
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Ewald Gelatin
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 FMC Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 GELITA USA Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Weishardt Holding
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Nitta Gelatin Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Norland Products Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Collagen Solutions Plc
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Jungbunzlauer Suisse AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Jiangxi Gelatin Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Qingdao Haizheng Gelatin Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Soochow University Gelatin Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 ShangHai Dingsheng Chemical Technology Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Grade Gelatin Market, By Application
    • 6.1.1 Nutraceuticals
    • 6.1.2 Pharmaceuticals
    • 6.1.3 Cosmetics
    • 6.1.4 Research Labs
  • 6.2 Pharmaceutical Grade Gelatin Market, By Product Type
    • 6.2.1 Hard Gelatin Capsules
    • 6.2.2 Soft Gelatin Capsules
    • 6.2.3 Gelatin Coated Tablets
    • 6.2.4 Hydrolyzed Gelatin
  • 6.3 Pharmaceutical Grade Gelatin Market, By Ingredient Type
    • 6.3.1 Type A Gelatin
    • 6.3.2 Type B Gelatin
    • 6.3.3 Type AB Gelatin
    • 6.3.4 Type O Gelatin
    • 6.3.5 Type S Gelatin
  • 6.4 Pharmaceutical Grade Gelatin Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Drug Stores
    • 6.4.3 Specialty Stores
    • 6.4.4 Direct Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Grade Gelatin Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Grade Gelatin market is categorized based on

By Product Type

• Hard Gelatin Capsules
• Soft Gelatin Capsules
• Gelatin Coated Tablets
• Hydrolyzed Gelatin

By Application

• Nutraceuticals
• Pharmaceuticals
• Cosmetics
• Research Labs

By Distribution Channel

• Online Stores
• Drug Stores
• Specialty Stores
• Direct Sales

By Ingredient Type

• Type A Gelatin
• Type B Gelatin
• Type AB Gelatin
• Type O Gelatin
• Type S Gelatin

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Gelita AG
• PB Gelatins
• FMC Corporation
• Jungbunzlauer Suisse AG
• Rousselot
• Ewald Gelatin
• GELITA USA Inc.
• Weishardt Holding
• Nitta Gelatin Inc.
• Collagen Solutions Plc
• ShangHai Dingsheng Chemical Technology Co., Ltd.
• Jiangxi Gelatin Co., Ltd.
• Norland Products Inc.
• Soochow University Gelatin Co., Ltd.
• Qingdao Haizheng Gelatin Co., Ltd.